Antibacterial and antifungal activities of neocryptolepine, biscryptolepine and cryptoquindoline, alkaloids isolated from Cryptolepis sanguinolenta

Phytomedicine

Volumn 5, Issue 3, 1998, Pages 209-214

  Cimanga, K ^a   De Bruyne, T ^a   Pieters, L ^a   Totte, J ^a   Tona, L ^b   Kambu, K ^b   Vanden Berghe, D ^a   Vlietinck, A J ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b UNIVERSITY OF KINSHASA   (Congo)

Author keywords

Alkaloids; Antibacterial and antifungal activities; Biscryptolepine; Cryptolepis sanguinolenta; Cryptoquindoline; Neocryptolepine

Indexed keywords

CRYPTOLEPIS; CRYPTOLEPIS SANGUINOLENTA; NEGIBACTERIA; POSIBACTERIA; UNIDENTIFIED AGENTS;

EID: 0000179037     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0944-7113(98)80030-5     Document Type: Article

References (36)

1. 13C-NMR assignments of cryptolepine, A 3:4 Benzo-o-carboline derivative isolated from Cryptolepis sanguinolenta. Planta Med. 56: 416-417, 1990.
2. Bamgbose, S. O. A, Noamesi, B. K.: Studies on cryptolepine II: Inhibition of carragean induced oedema by cryptolepine. Planta Med. 41: 392-396, 1981.
3. Boye, L. G., Ampofo, O.: Medicinal plants in Ghana. In Economic and Medicinal Plant Research. Vol. 4. Plants and Traditional Medicine. Eds.: Wagner and Fransworth, N. R. Academic Press. London. 1990: pp. 32-33.
4. Cimanga, K., Pieters, L., Claeys, M., Vanden Berghe, D., Vlietinck, A. J.: Biological activities of cryptolepine, an alkaloid from Cryptolepis sanguinolenta. Planta Med 57, Supplement Issue 2: A98-A99, 1991.
5. Cimanga, K., T. De Bruyne, Pieters, L., Claeys, M., Vlietinck, A. J.: New alkaloids from Cryptolepis sanguinolenta. Tetrahedron Letters 37: 1703-1706, 1996a.
6. Cimanga, K., T. De Bruyne, Van Poel, B., Pieters, L, Vanden Berghe, A., Vlietinck, A. J. et al.: In vitro biological activities of alkaloids from Cryptolepis sanguinolenta. Planta Med. 62: 22-27, 1996b.
7. Cimanga, K., T. De Bruyne, Pieters, L., Turger, C. A., Vlietinck, A. J.: In vitro and in vivo antiplasmodial activity of cryptolepine and related alkaloids from Cryptolepis sanguinolenta. J. Nat. Prod. 60: 688-691, 1997.
8. 15N heteronuclear shift correlation: experiments using micro inverse-detection. J. Heterocyclic Chem. 32: 1077-1080, 1995.
9. Dwuma-Badu, D., Ayim, J. S. K., Fiagbe, N. I. Y., Knapp, Ph. E., Schiff, Jr. P. L., Slatkin, D. J.: Constituents of West African medicinal plants XX: Quindoline from Cryptolepis sanguinolenta. J. Pharm. Sci. 67: 433-434, 1978.
10. Dwuma-Badu, D.: A review of studies on the constituents of three West African medicinal plants. Fitoterapia 58: 348-349, 1987.
11. Gellert, E., Raymont-Hamet, Schlittler, E.: Die Konstitution des Alkaloids Cryptolepin. Helv. Chim. Acta. 34: 642-651, 1951.
12. Grellier, P., Ramiaramanana, L., Milleriox, V., Deharo, E, Shrevel, J., Frappier, F. et al.: Antimalarial activity of cryptolepine and isocryptolepine, alkaloids isolated from Cryptolepis sanguinolenta. Phytother. Res. 10: 317-321, 1996.
13. Kerharo, J., Adam, J. G.: La pharmacopée sénégalaise traditionnelle. Plantes médicinales et toxiques. Vigot et Frères. Paris, pp. 632-633, 1974.
14. Kirby, C. C., Paine, A., Warhurst, C., Noamesi, B. K., Phillipson, J. D.: In vitro and in vivo antimalarial activity of cryptolepine, a plant-derived indoloquinoline. Phytother. Res. 9: 359-363, 1995.
15. Noamesi, B. K., Bamgbose, S. O. A.: The alpha-adrenoceptor blocking properties of cryptolepine on the rat isolated vas deferens. Planta Med. 39: 51-56, 1980.
16. Noamesi, B. K., Paine, A., Kirby, G. C., Warhurst, D. C., Phillipson, J. D.: In vitro antimalarial activity of cryptolepine, an indoloquinolone. Trans. Roy. Soc. Trop. Med. Hygiene, 85: 315, 1991.
17. Noamesi, B. K., Bamgbose, S. O. A.: Preferential Blockade of pre-synaptic alpha-adrenoceptors on the rat isolated vas deferens by cryptolepine, 7: Studies on cryptolepine. Planta Med 44: 241-245, 1982.
18. 2 on rat isolated mesenteric artery. Planta Med. 47: 100-102, 1983a.
19. Noamesi, B. K., Bamgbose, S. O. A.: Studies on cryptolepine: Effect of cryptolepine on smooth muscle contractions and cholinergic nerve transmission of isolated guinea-pig ileum. Planta Med. 48: 48-51, 1983b.
20. Noamesi, B. K., Bamgbose, S. O. A.: Studies on cryptolepine III: Effect of cryptolepine on the tone and prostaglandin production in isolated rabbit duodenum. Planta Med. 50: 98-101, 1984.
21. Oyekan, A. O., Botting, J. H., Noamesi, B. K.: Cryptolepine inhibits platelets aggregation in vitro and in vivo and stimulates fibrinolysis ex vivo. Gen. Pharmacol. 19: 233-237, 1988.
22. Oyekan, A. O., Okafor, J. P. O.: Effects of cryptolepine alone in combination with dipyridamole on a mouse model of arterial thrombosis. J. Ethnopharmacol. 27: 141-148, 1989.
23. Paulo, A., Pimentel, M., Viegas, S., Pires, I., Duarte, A., Cabrita, J. et al.: Cryptolepis sanguinolenta activity against diarrhoeal bacteria. J. Ethnopharmacol. 44: 73-77, 1994a.
24. Paulo, A., Duarte, A., Gomes, E. T.: In vitro antibacterial screening of Cryptolepis sanguncolenta alkaloids. J. Ethnopharmacol. 44: 127-130, 1994b.
25. Paulo, A., Gomes, E. T., Houghton, P. J.: New alkaloids from Cryptolepis sanguinolenta. J. Nat. Prod. 58: 1485-1491, 1995.
26. Pousset, J. L., Martin, M. T., Jossang, A., Bodo, B.: Isocryptolepine from Cryptolepis sanguinolenta. Phytochemistry 39: 735-736, 1995.
27. Sawer, I. K., Berry, M. I., Brown, M. W., Ford, J. L.: The effect of cryptolepine on the morphology and survival of Escherichia coli, Candida albicans and Saccharomyces cerevisiae. J. Appl. Bact. 79: 314-321, 1995.
28. Sharaf, M. H. M., Schiff, Jr. P. L., Tackie, A. N., Phoebe, Jr. C. H., Davis, A. O., Andrews C. W. et al.: Isolation and elucidation of the structure of homocryptolepinone. J. Heterocyclic Chem. 32: 1631-1636, 1995a.
29. Sharaf, M. H. M., Schiff, Jr. P. L., Tackie, A. N., Phoebe, Jr. C. H., Howard, L., Meyers, C. et al.: Submicromole structure elucidation: Cryptolepicarboline, a novel dimeric alkaloid from Cryptolepis sanguinolenta. Magn. Reson. Chem. 33: 767-778, 1995b.
30. Sharaf, M. H. M., Schiff, Jr. P. L., Tackie, A. N., Phoebe, Jr. C. H., Martin, G. E.: Two new indoloquinoline alkaloids from Cryptolepis sanguinolenta: cryptosanguinolentine and cryptotackieine. J. Heterocyclic Chem. 33: 239-243, 1996a.
31. Sharaf, M. H. M., Schiff, Jr. P. L., Tackie, A. N., Phoebe, Jr. C. H., Johnson, R. L., Minick, D. et al.: The isolation and structure determination of cryptomisrine, a novel indolo[3,2-b] dimeric alkaloid from Cryptolepis sanguinolenta. J. Heterocyclic Chem. 33: 789-797, 1996b.
32. Sofowora, A.: Medicinal Plants and Traditional Medicine in Africa. John Wiley and Sons limited. Chichester. pp. 221-223, 1982.
33. Tackie, A. N., Sharaf, M. M. H., Schiff, Jr. P. L., Boye, G. L., Crouch, R. C., Martin, G. E.: Assignment of the proton and carbon NMR spectra of the indoloquinoline alkaloid cryptolepine. J. Heterocylic Chem. 28: 1421-4359, 1991.
34. Tackie, A. N., Boye, G. L., Sharaf, M. H. M., Schiff, Jr. P. L., Crouch, R. C., Spitzer, et al.: Cryptospirolepine, an unique spiro-nonacyclic alkaloid isolated from Cryptolepis sanguinolenta. J. Nat. Prod. 56: 653-670, 1993.
35. Vanden Berghe, D. A., Vlietinck, A. J.: Screening for antibacterial and antiviral agents. In: Plant Biochemistry. Vol. 6. Assays for Bioactivity. Ed. K. Hostettmann. Academic Press, London, 1991: 47-70.
36. Wright, C. W., Phillipson, J. D., Awe, S. O., Kirby, G. C., Warhurst, D. C., Quetin-Leclerq, J. et al.: Antimalarial activity of cryptolepine and some other anhydronium bases. Phytother. Res. 10: 361-363, 1996.